LEADER 04504nam 22006135 450 001 9910886990103321 005 20250807133224.0 010 $a3-031-57369-2 024 7 $a10.1007/978-3-031-57369-9 035 $a(MiAaPQ)EBC31650794 035 $a(Au-PeEL)EBL31650794 035 $a(CKB)34843066800041 035 $a(DE-He213)978-3-031-57369-9 035 $a(OCoLC)1456758307 035 $a(EXLCZ)9934843066800041 100 $a20240905d2024 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aGlobal Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century /$fedited by Charurut Somboonwit, Paul Shapshak, Pandjassarame Kangueane, S. Balaji, John T. Sinnott, Lynette J. Menezes, Asa Oxner 205 $a1st ed. 2024. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2024. 215 $a1 online resource (372 pages) 311 08$a3-031-57368-4 320 $aIncludes bibliographical references and index. 327 $a -- 1. The genome sequence analysis of SARS- CoV-2 variants of concern -- 2. Influenza: Clinical challenges in the 21st century -- 3. Ebola: Virology, clinical considerations, and outbreak response and prevention -- 3. A clinical approach to novel diagnostics and therapeutics: The challenge of Zika -- .5 Oncogenic human papillomavirus -- 6. Hepatitis C virus infection in people who inject drugs -- 7. Hepatitis C: Updates in epidemiology and treatment with direct-acting antivirals -- 8. NeuroAIDS, comorbid mood disorders and neuropsychiatric effects of antiretroviral therapy -- 9. Marijuana and HIV -- 10. Mpox: An emerging global orthopoxvirus outbreak -- 11. Community-acquired respiratory infections in HCT and immunosuppressed patients -- 12. COVID-19 in cancer and hematopoietic stem cell transplant recipients -- 13. Epstein-Barr virus: Acute infection, oncogenesis, prevention and pitfalls -- 14. Human herpesvirus 6A, 6B, 7 and 8 in hematopoietic stem cell transplant: A clinical review -- 15. Cytomegalovirus infections in hematopoietic cell transplant and solid organ transplant recipients -- 16. Herpes simplex virus and varicella zoster virus in hematopoietic stem cell transplant recipients -- 17. The virology of hemophagocytic lymphohistiocytosis -- 18. Antiviral agents: Cidofovir and Brincidofovir -- 19. Antiviral agents: Ganciclovir and valganciclovir -- 20. Antiviral agents: Letermovir -- 21. Antiviral agents: Maribavir -- 22. Antiviral agents in the hematopoietic stem cell transplant population: Acyclovir, valacyclovir, penciclovir and famciclovir -- 23. Antiviral agents in the hematopoietic stem cell transplant population: Foscarnet -- 24. Radioimmunotherapy: An overview. 330 $aIn the face of recent viral outbreaks and a global viral pandemic, the necessity for innovation and continued rapid advancement in viral diagnosis and treatment methods has become even more apparent. Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century explores the latest advances in virology and trends in clinical practice, focused on foundational principles and advancements expected to significantly impact this field. Chapters address SARS-CoV-2, Ebola, Zika, Mpox, and Hepatitis C, among other key viral threats, before presenting a detailed analysis of antiviral agents broadly and concerning specific vulnerable populations such as stem cell and solid organ transplant recipients. It is designed as a helpful resource for medical students, scientists, and professionals, bridging current practice and future applications and inspiring further innovations and improvements in global health. 606 $aVirology 606 $aNeurosciences 606 $aImmunology 606 $aPharmacology 606 $aVirology 606 $aNeuroscience 606 $aImmunology 606 $aPharmacology 615 0$aVirology. 615 0$aNeurosciences. 615 0$aImmunology. 615 0$aPharmacology. 615 14$aVirology. 615 24$aNeuroscience. 615 24$aImmunology. 615 24$aPharmacology. 676 $a616.91 702 $aSomboonwit$b Charurut 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910886990103321 996 $aGlobal Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century$94430938 997 $aUNINA